PATENT CLAIM ANALYSIS

Application Number: 16060109
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "004800"]

Abstract:
The invention provides compositions and methods for inhibiting protein-protein interactions with cap-binding protein 80 (CBP80). In one embodiment, the invention provides compositions comprising linear and macrocylic peptides. In one embodiment, the invention provides methods for treating cancer, heart disease, autoimmune disorders, obesity, diabetes, or chronic inflammation disorders associated with the PGC1 family of co-activators.

Claim (Index 20):
The peptide of  claim 19 , wherein the electrophilic group capable of reacting with cysteine is selected from the group consisting of wherein R is selected from the group consisting of a C 3 -C 20  alkyl, C 3 -C 20  heteroalkyl, C 6 -C 10  aryl, and C 6 -C 10  heteroaryl group.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.53488
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14398260', '15941030', '14800627', '14118545', '09825517']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8602725515018128
- 35 USC 102 Novelty (BERT): 0.5816500678629286
- Combined Prediction Score: 0.8324103031379244
- Mean Citation Score: 553.978646
- Max Citation Score: 558.4818
- Similarity Product: 372.451001434207

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test